Soluble vascular endothelial growth factor receptor 1 (VEGFR1): A possible biomarker in BPS/IC?
Introduction:: Interstitial cystitis/bladder pain syndrome (IC/BPS) pathophysiology is not fully understood. Vascular endothelial growth factor (VEGF) has been implicated in bladder vasculature alterations and nociception, but the role of its soluble receptor, VEGFR1, remains poorly explored. This s...
Saved in:
| Main Authors: | Pedro Abreu-Mendes, Rui Almeida Pinto, Diogo Dias, Francisco Cruz, Ana Charrua |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Continence |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772973725001559 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancing Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Diagnosis: A Comparative Analysis of Machine Learning Methodologies
by: Joseph J. Janicki, et al.
Published: (2024-12-01) -
The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
by: Yuan-Hong Jiang, et al.
Published: (2023-01-01) -
Cystoscopic characteristic findings of interstitial cystitis and clinical implications
by: Wan-Ru Yu, et al.
Published: (2024-01-01) -
PACAP/PAC1 regulation in cystitis rats: induction of bladder inflammation cascade leading to bladder dysfunction
by: Hanwei Ke, et al.
Published: (2024-11-01) -
Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency
by: Qian-Sheng Ke, et al.
Published: (2019-01-01)